Cargando…
Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study
Patients with Chronic Obstructive Pulmonary Disease (COPD) periodically experience acute exacerbation (AECOPD). Carbocysteine represents a valid add on therapy in COPD by exerting antioxidant and anti-inflammatory activities. The in vivo effects of carbocysteine on inflammatory markers are not yet f...
Autores principales: | Ferraro, Maria, Di Vincenzo, Serena, Sangiorgi, Claudia, Leto Barone, Stefania, Gangemi, Sebastiano, Lanata, Luigi, Pace, Elisabetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880736/ https://www.ncbi.nlm.nih.gov/pubmed/35215330 http://dx.doi.org/10.3390/ph15020218 |
Ejemplares similares
-
Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action
por: Pace, Elisabetta, et al.
Publicado: (2022) -
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019) -
Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014) -
Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020) -
sRAGE and early signs of cardiac target organ damage in mild hypertensives
por: Maresca, Andrea Maria, et al.
Publicado: (2019)